Document Detail

Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced?
MedLine Citation:
PMID:  18203763     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: To describe and analyse the manifestation of sclerosing skin disorders in patients with multiple sclerosis (MS). CASE REPORTS: We describe three patients with relapsing-remitting MS who developed skin sclerosis while receiving interferon (IFN)-beta treatment and review nine further cases of systemic sclerosis (SSc) in MS from the literature. Of all 12 patients reported, eight had limited cutaneous SSc, three had diffuse cutaneous SSc and one patient had an antisynthetase syndrome. Localised scleroderma such as morphoea was not described. The mean age at diagnosis was 25.2 years for MS (range 12 to 51) and 38.3 years for SSc (range 16 to 66). Eleven patients developed SSc after the onset of MS and manifested with skin sclerosis after a mean of 14.9 years (range 1 to 45). In five patients IFN-beta was commenced before the development of skin sclerosis (mean 4.6 years, range 1 to 8 years). There was no relationship between the onset of skin sclerosis and MS activity. With the exception of one individual, all patients had antinuclear antibodies. CONCLUSIONS: Sclerosing skin disorders may develop in the course of MS. The relatively early age of SSc onset in patients with MS suggests a genetic predisposition and/or an IFN-associated trigger.
T Hügle; S Gratzl; T Daikeler; D Frey; A Tyndall; U A Walker
Related Documents :
15081263 - Hla-multiple sclerosis association in continental italy and correlation with disease pr...
17558833 - Hla typing in vogt-koyanagi-harada syndrome in north indian patients.
24213913 - Adequacy of an evidence-based treatment guideline for complicated urinary tract infecti...
Publication Detail:
Type:  Case Reports; Journal Article; Review     Date:  2008-01-18
Journal Detail:
Title:  Annals of the rheumatic diseases     Volume:  68     ISSN:  1468-2060     ISO Abbreviation:  Ann. Rheum. Dis.     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2008-12-17     Completed Date:  2009-01-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372355     Medline TA:  Ann Rheum Dis     Country:  England    
Other Details:
Languages:  eng     Pagination:  47-50     Citation Subset:  IM    
Felix Platter Spital, Basel University Department of Rheumatology, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adjuvants, Immunologic / adverse effects,  therapeutic use
Interferon-beta / adverse effects,  therapeutic use
Middle Aged
Multiple Sclerosis, Relapsing-Remitting / complications*,  immunology
Raynaud Disease / complications,  immunology
Scleroderma, Diffuse / complications*,  immunology
Time Factors
Reg. No./Substance:
0/Adjuvants, Immunologic; 77238-31-4/Interferon-beta

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The synovitis of "non-inflammatory" orthopaedic arthropathies: a quantitative histological and immun...
Next Document:  Level of radiographic damage and radiographic progression are determinants of physical function: a l...